These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36494319)

  • 1. Specialty specific quality measures needed to improve outcomes in wound care.
    Tettelbach W; Forsyth A
    Int Wound J; 2023 May; 20(5):1662-1666. PubMed ID: 36494319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of dehydrated human amnion/chorion membrane allografts in lower extremity diabetic ulcer treatment.
    Tettelbach WH; Armstrong DG; Chang TJ; Jong JL; Glat PM; Hsu JH; Kelso MR; Niezgoda JA; Labovitz JM; Hubbs B; Forsyth RA; Cohen BG; Reid NM; Padula WV
    J Wound Care; 2022 Feb; 31(Sup2):S10-S31. PubMed ID: 35148642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observed impact of skin substitutes in lower extremity diabetic ulcers: lessons from the Medicare Database (2015-2018).
    Armstrong DG; Tettelbach WH; Chang TJ; De Jong JL; Glat PM; Hsu JH; Kelso MR; Niezgoda JA; Tucker TL; Labovitz JM
    J Wound Care; 2021 Jul; 30(Sup7):S5-S16. PubMed ID: 34256590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of adequate debridement and placental-derived allografts on diabetic foot ulcers.
    Tettelbach WH; Cazzell SM; Hubbs B; Jong JL; Forsyth RA; Reyzelman AM
    J Wound Care; 2022 Sep; 31(Sup9):S16-S26. PubMed ID: 36113857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic foot ulcers: weekly versus second-weekly conservative sharp wound debridement.
    Nube VL; Alison JA; Twigg SM
    J Wound Care; 2023 Jun; 32(6):383-390. PubMed ID: 37300856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative analysis of skin substitutes used in the management of diabetic foot ulcers.
    Martinson M; Martinson N
    J Wound Care; 2016 Oct; 25(Sup10):S8-S17. PubMed ID: 27681811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment patterns and outcomes of Medicare enrolees who developed venous leg ulcers.
    Tettelbach WH; Driver V; Oropallo A; Kelso MR; Niezgoda JA; Wahab N; De Jong JL; Hubbs B; Forsyth RA; Magee GA
    J Wound Care; 2023 Nov; 32(11):704-718. PubMed ID: 37907359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic outcomes among Medicare patients receiving bioengineered cellular technologies for treatment of diabetic foot ulcers.
    Rice JB; Desai U; Ristovska L; Cummings AK; Birnbaum HG; Skornicki M; Margolis DJ; Parsons NB
    J Med Econ; 2015; 18(8):586-95. PubMed ID: 25786331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proximal Tibial Cortex Transverse Distraction Facilitating Healing and Limb Salvage in Severe and Recalcitrant Diabetic Foot Ulcers.
    Chen Y; Kuang X; Zhou J; Zhen P; Zeng Z; Lin Z; Gao W; He L; Ding Y; Liu G; Qiu S; Qin A; Lu W; Lao S; Zhao J; Hua Q
    Clin Orthop Relat Res; 2020 Apr; 478(4):836-851. PubMed ID: 31794478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(7):1-165. PubMed ID: 34211616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors for treating diabetic foot ulcers.
    Martí-Carvajal AJ; Gluud C; Nicola S; Simancas-Racines D; Reveiz L; Oliva P; Cedeño-Taborda J
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD008548. PubMed ID: 26509249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the Effect of the Five-in-One Comprehensive Limb Salvage Technologies of Treating Severe Diabetic Foot.
    Liu Y; Shi Y; Zhu J; Chen X; Yang R; Shu B; Zhou Z; Liu J; Wu RQ; Xie J
    Adv Wound Care (New Rochelle); 2020 Dec; 9(12):676-685. PubMed ID: 33124965
    [No Abstract]   [Full Text] [Related]  

  • 16. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
    Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
    Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of diabetic foot infections.
    Lipsky BA; Berendt AR; Deery HG; Embil JM; Joseph WS; Karchmer AW; LeFrock JL; Lew DP; Mader JT; Norden C; Tan JS;
    Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):212S-238S. PubMed ID: 16799390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
    O'Meara S; Cullum N; Majid M; Sheldon T
    Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.